After 8 weeks of intervention, the intervention group showed significant improvements in obesity indices (body weight, BMI, and PBF), lipid profiles (TG, TC, LDL-C, and HDL-C), FBS, insulin levels, and HOMA-IR and HOMA-B (p < 0.001). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.